Nichi-Iko Pharmaceutical
Japan - Toyama-shiPharmaceutical
Focus: Nichi-Iko Pharmaceutical is a Japan-based generic drug developer, manufacturer, and distributor with a focus on neurology and expanding immunology indications. The company operates as a mid-sized player in the generics and specialty pharmaceuticals space.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Nichi-Iko Pharmaceutical
AI assessmentNot HiringNo open roles listed right now. Follow Nichi-Iko Pharmaceutical to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Infliximab
Rheumatoid ArthritisClinical Trials (1)
NCT01567358Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis
Phase 1Help build intelligence for Nichi-Iko Pharmaceutical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.